☰

Sean M. Emery - Publications

Affiliations: 
2014 Pharmacology  Virginia Commonwealth University, Richmond, VA, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Emery SM, Alotaibi MR, Tao Q, Selley DE, Lichtman AH, Gewirtz DA. Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. The Journal of Pharmacology and Experimental Therapeutics. 348: 293-302. PMID 24259678 DOI: 10.1124/Jpet.113.205120  0.466
2013 Schneider K, Nwizu C, Kaplan R, Anderson J, Wilson DP, Emery S, Cooper DA, Boyd MA. The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa. Plos One. 8: e54435. PMID 23457450 DOI: 10.1371/journal.pone.0054435  0.314
2013 Bristol ML, Emery SM, Maycotte P, Thorburn A, Chakradeo S, Gewirtz DA. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? The Journal of Pharmacology and Experimental Therapeutics. 344: 544-52. PMID 23291713 DOI: 10.1124/Jpet.112.199802  0.379
2012 Emery SM, Sumner ET, Lichtman AH, Gewirtz DA. Abstract 1453: The cannabinoid Win55, 212-2 enhances the response of breast cancer cells to radiation Cancer Research. 72: 1453-1453. DOI: 10.1158/1538-7445.Am2012-1453  0.449
Show low-probability matches.